Venture capital firm General Catalyst announced the expansion of the General Catalyst Institute into India, focusing on five key pillars, including using AI to address societal challenges and working with policymakers and entrepreneurs to build on India's strengths in telemedicine and pharmaceuticals in order to impact the healthcare sector.
The General Catalyst Institute, launched in September,...
A consortium of research institutes in South Korea has been formed to promote the utilisation of AI and national supercomputers in discovering novel drugs for treating lung cancer.
According to a press statement, the following organisations will collaborate to develop and test AI for identifying novel drug candidates and predicting its efficacy:
DAAN Cancer Research Institute under Yonsei...
The Society of General Internal Medicine released a position statement on generative AI use in healthcare, highlighting the need for clinicians and technologists to partner to enhance genAI decision-making and for healthcare organizations to use the technology but, avoid "the urge to rapidly displace the human clinical workforce with generative AI."
The Society says clinicians must remain...
Digital biology company Optic is collaborating with early-stage oncology therapeutics venture, Vindur Tx, to use Optics proprietary generative AI platform to find novel highly selective kinase inhibitors and develop more effective cancer treatments.
Vindur Tx agreed to pay Optic as much as $17.5 million for its proprietary technology to search for new ways of addressing what the company called...
Precision Neuroscience, a brain-computer interface company that connects AI with human intelligence, has scored $93 million in a planned $100 million funding round, with the deal valuing the startup at around $500 million, according to a Bloomberg report that attributes the information to "a person familiar with the situation."
WHAT IT DOES
Private company Precision Neuroscience offers a brain...
Life sciences-focused technology company MGI Tech announced a commercial partnership with Human Cell Atlas, a global consortium working to map every cell type in the human body, to advance worldwide human cell mapping.
MGI Tech is a Chinese biotechnology company that offers a high-throughput genome-sequencing machine, genetic sequencers, and other tools and technologies that can be applied to...
Neurophet sets up China JV
Medical imaging AI company Neurophet from South Korea has established a joint venture in China.
It recently signed an exclusive deal with LADO, one of the leading medical software providers in China, to market its AI-based software for quantifying levels of Alzheimer's disease biomarkers in PET images.
The deal, which also establishes a joint venture with LADO, aims...
Therapeutic extended reality platform XRHealth announced it acquired cognitive training VR platform NeuroReality and its assets, including its main product, Koji's Quest.
Boston-based XRHealth offers a catalog of immersive medical extended reality (XR) experiences focused on the physical and cognitive space, including symptom management, meditation exercises, upper extremity rehabilitation,...
Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat neovascular age-related macular degeneration (nAMD), dubbed HG202, developed using machine learning and AI.
The company used its HG-PRECISE platform (HuidaGene – Platform for Rational Engineering of...
